| Dr Gwyn Elann King, DO | |
|
7249 Liberty Way Ste 100, West Chester, OH 45069-1518 | |
| (513) 770-3263 | |
| (937) 293-5568 |
| Full Name | Dr Gwyn Elann King |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 7249 Liberty Way Ste 100, West Chester, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659569382 | NPI | - | NPPES |
| 1659569382 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 34.010052 (Ohio) | Primary |
| 207N00000X | Dermatology | 249624 (New York) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology And Skin Care Associates Llc | 0244365260 | 6 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine.
Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
There is a great deal of interest in the impact of lactic acid bacteria on our health. Now a new study from the Faculty of Health and Society, Malmö University, in Sweden, shows that the occurrence of Lactobacillus reuteri in the body promotes health.
› Verified 5 days ago
| Entity Name | Dayton Skin Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710932454 PECOS PAC ID: 2365455276 Enrollment ID: O20060719000087 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine.
Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
There is a great deal of interest in the impact of lactic acid bacteria on our health. Now a new study from the Faculty of Health and Society, Malmö University, in Sweden, shows that the occurrence of Lactobacillus reuteri in the body promotes health.
› Verified 5 days ago
| Entity Name | Dermatology & Skin Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033444997 PECOS PAC ID: 0244365260 Enrollment ID: O20100316000875 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine.
Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
There is a great deal of interest in the impact of lactic acid bacteria on our health. Now a new study from the Faculty of Health and Society, Malmö University, in Sweden, shows that the occurrence of Lactobacillus reuteri in the body promotes health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gwyn Elann King, DO 7249 Liberty Way Ste 100, West Chester, OH 45069-1518 Ph: (513) 770-3263 | Dr Gwyn Elann King, DO 7249 Liberty Way Ste 100, West Chester, OH 45069-1518 Ph: (513) 770-3263 |
News Archive
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that a poster on its oral synthetic growth hormone secretagogue/ghrelin receptor agonist, AEZS-130, was presented yesterday at the 92nd Annual Endocrine Society (ENDO) Meeting and Expo, which is held through June 22, 2010 at the San Diego Convention Center in San Diego, California.
Researchers have demonstrated a new imaging tool for tracking structures called carbon nanotubes in living cells and the bloodstream, which could aid efforts to perfect their use in biomedical research and clinical medicine.
Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.
The Associated Press: "In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. … The measure would ban a 'pay-to-delay' practice — opposed by the [Federal Trade Commission] in a series of lawsuits brought since 2001 — in which brand-name drug companies and generic drug makers both profit. Brand-name drug makers get higher prices while the generic companies are paid to stay out of the market."
There is a great deal of interest in the impact of lactic acid bacteria on our health. Now a new study from the Faculty of Health and Society, Malmö University, in Sweden, shows that the occurrence of Lactobacillus reuteri in the body promotes health.
› Verified 5 days ago
Mohammad Diab, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8040 Princeton-glendale Rd, West Chester, OH 45069 Phone: 513-246-7000 Fax: 513-246-5479 | |
Dr. Elizabeth A. L. Muennich, M.D. PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7249 Liberty Way Ste 100, West Chester, OH 45069 Phone: 513-770-3263 Fax: 513-770-3295 | |
D Mark Oelrich, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7665 Monarch Court, Ste 107, West Chester, OH 45069 Phone: 513-779-1800 Fax: 513-779-1901 | |
Dr. Jane Glenchur, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 6547 Butterfly Way, West Chester, OH 45069 Phone: 513-739-5300 | |
Dena M Elkeeb, MD Dermatology Medicare: Medicare Enrolled Practice Location: 7249 Liberty Way Ste 100, West Chester, OH 45069 Phone: 513-770-3263 |